Photopheresis therapy for problematic renal allograft rejection

Journal of Clinical Apheresis

Volumn 24, Issue 4, 2009, Pages 161-169

  Jardine, Meg J ^a,b   Bhandari, Sunil ^a,c   Wyburn, Kate R ^a   Misra, Ashish K ^a,d   McKenzie, Paul R ^a   Eris, Josette M ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

^c HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^d Haematology and Oncology Clinics of Australasia   (Australia)

Author keywords

Infection; Malignancy; Photopheresis; Rejection; Renal

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; COMPLEMENT COMPONENT C4D; CYCLOSPORIN A; EVEROLIMUS; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADJUVANT THERAPY; ADULT; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MALIGNANT NEOPLASTIC DISEASE; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PUVA; RECURRENT DISEASE; SALVAGE THERAPY; SEPSIS;

ADULT; BIOPSY; COMPLEMENT C4B; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PHOTOPHERESIS; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 69249154766     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20199     Document Type: Article

References (26)

1. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, Vonderheid E, Knobler R, Wolff K, Plewig, G. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: preliminary results. N Engl J Med 1987;316:297-303.
2. McKenna KE, Whittaker S, Rhodes LE, Taylor P, Lloyd J, Ibbotson S, Russell-Jones R. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology group and the U.K. skin lymphoma group. Br J Dermatol 2006;154:7-20.
3. O'Hagan AR, Stillwell PC, Arroliga A, Koo A. Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation. Chest 1999;115:1459-1462.
4. Barr ML, Meiser BM, Eisen HJ, Roberts RF, Livi U, Dall' Amico R. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med 1998;339:1744-1751.
5. Horina JH, Mullegger RR, Horn S, Holzer H, Halwachs G, Kerl H, Wolf P. Photopheresis for renal allograft rejection. Lancet 1995;346:61.
6. Sunder-Plassman G, Druml W, Steininger R, Honigsmann H, Knobler R. Renal allograft rejection controlled by photopheresis. Lancet 1995;346:506.
7. Wolfe JT, Tomaszewski JE, Grossman RA, Gottlieb SL, Naji A, Brayman KL, Kobrin SM, Rook AH. Reversal of acute renal allograft rejection by extracorporeal photopheresis: a case presentation and review of the literature. J Clin Apher 1996;11:36-41.
8. Dall'Amico R, Murer L, Montini G, Andreetta B, Zanon GF, Zacchello G, Zacchello F. Successful treatment of recurrent rejection in renal transplant patients with photopheresis. J Am Soc Nephrol 1998;9:121-127.
9. Baron ED, Heeger PS, Hricik DE, Schulak JA, Tary-Lehmann M, Stevens SR. Immunomodulatory effect of extracorporeal photopheresis after successful treatment of resistant renal allograft rejection. Photodermatol Photoimmunol Photomed 2001;17:79-82.
10. Kumlien G, Genberg H, Shanwell A, Tyden G. Photopheresis for the treatment of refractory renal graft rejection. Transplantation 2005;79:123-125.
11. Dall'Amico R, Murer L. Extracorporeal photochemotherapy: a new therapeutic approach for allograft rejection. Transfus Apher Sci 2002;26:197-204.
12. Genberg H, Kumlien G, Shanwell A, Tyden G. Refractory acute renal allograft rejection successfully treated with photopheresis. Transplant Proc 2005;37:3288-3289.
13. Lamioni A, Carsetti R, Legato A, Landolfo A, Isacchi G, Emma F, Bottazzo GF, Strologo LD. Induction of regulatory T cells after prophylactic treatment with photopheresis in renal transplant recipients. Transplantation 2007;83:1393-1396.
14. Maeda A, Schwarz A, Kernebeck K, Gross N, Aragane Y, Peritt D, Schwarz T. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 2005;174:5968-5976.
15. Yoo EK, Rook AH, Elenitsas R, Gasparro FP, Vowels BR. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996;107:235-242.
16. Bladon J, Taylor PC. Extracorporeal photopheresis: a focus on apoptosis and cytokines. J Dermatol Sci 2006;43:85-94.
17. Lamioni A, Parisi F, Isacchi G, Giorda E, Di Cesare S, Landolfo A, Cenci F, Bottazzo GF, Carsetti R. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 2005;79:846-850.
18. Morelli AE. The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: its impact on transplantation. Am J Transplant 2006;6:254-261.
19. Bittencourt MC, Perruche S, Contassot E, Fresnay S, Baron MH, Angonin R, Angonin R, Aubin F, Hervé P, Tiberghien P, Saas P. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 2001;98:224-230.
20. Di Renzo M, Rubegni P, Pasqui AL, Pompella G, De Aloe G, Sbano P, Cuccia A, Castagnini C, Auteri A, Pasini F Laghi, Fimiani M. Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease. Br J Dermatol 2005;153:59-65.
21. Tokura Y, Seo N, Yagi H, Takigawa M. Photoactivational cytokine- modulatory action of 8-methoxypsoralen plus ultraviolet A in lymphocytes, monocytes, and cutaneous T cell lymphoma cells. Ann N Y Acad Sci 2001;941:185-193.
22. Silva MG, Ferreira Neto L, Guimaraes A, Machado A, Parreira A, Abecasis M. Long-term follow-up of lymphocyte populations and cellular cytokine production in patients with chronic graft-versus-host disease treated with extracorporeal photopheresis. Haematologica 2005;90:565-567.
23. Yamashita K, Horwitz ME, Kwatemaa A, Nomicos E, Castro K, Sokolic R, Foster S, Garofalo M, Choi U, RyherdM. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis. Biol Blood Marrow Transplant 2006;12:22-30.
24. Rook AH, Suchin KR, Kao DM, Yoo EK, Macey WH, DeNardo BJ, Bromely PG, Geng Y, Junkins-Hopkins JM, Lessin SR. Photopheresis: clinical applications and mechanism of action. J Investig Dermatol Symp Proc 1999;4:85-90.
25. Heshmati F. Mechanisms of action of extracorporeal photochemotherapy. Transfus Apher Sci 2003;29:61-70.
26. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004;4:905-913.